Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04730258
Title A Study of CFI-400945 With or Without Azacitidine or Decitabine in Patients With AML, MDS or CMML (TWT-202)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Treadwell Therapeutics, Inc
Indications

acute myeloid leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

CFI-400945

CFI-400945 + Decitabine

Azacitidine + CFI-400945

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.